Arcellx Inc (ACLX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Rami Elghandour
Employees:
80
25 WEST WATKINS MILL ROAD, SUITE A, GAITHERSBURG, MD 20878
240-723-6641

Arcellx, Inc. engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM) It is also developing ACLX-001, an immunotherapeutic combination composed of ARC-T cells and bi-valent SparX proteins.

Data derived from most recent annual or quarterly report
Market Cap 2.669 Billion Shares Outstanding48.359 Million Avg 30-day Volume 776.935 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.12
Price to Revenue36.8438 Debt to Equity0.0 EBITDA-136.212 Million
Price to Book Value6.5305 Operating Margin-307.14209999999997 Enterprise Value1.255 Billion
Current Ratio2.838 EPS Growth0.936 Quick Ratio2.721
1 Yr BETA 0.9411 52-week High/Low 56.09 / 18.7 Profit Margin-274.5882
Operating Cash Flow Growth230.5114 Free Cash Flow to Firm (FCFF) TTM 97.688 Million Free Cash Flow to Equity (FCFE) TTM-118.828 Million
Altman Z-Score2.0657
View SEC Filings from ACLX instead.

View recent insider trading info

Arcellx Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding ACLX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ACLX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-08-07 by HEERY CHRISTOPHER
  • 4: filed on 2023-07-05 by HEERY CHRISTOPHER
  • 4: filed on 2023-05-25 by GILSON MICHELLE
  • 4: filed on 2023-05-15 by CARROLL JILL
  • 4: filed on 2023-05-15 by GEORGE SIMEON
  • 4: filed on 2023-05-11 by HEERY CHRISTOPHER
  • 4: filed on 2023-05-08 by HEERY CHRISTOPHER
  • 4: filed on 2023-05-05 by HEERY CHRISTOPHER
  • 4: filed on 2023-04-26 by HEERY CHRISTOPHER
  • 4: filed on 2023-04-20 by HEERY CHRISTOPHER

    • Events (8k)

  • 8-K: filed on 2023-11-15:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-11-13:
    Item 2.02: Results of Operations and Financial Condition
  • 8-K: filed on 2023-11-02:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-14:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-20:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-14:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-05-08:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-08:
    Item 2.02: Results of Operations and Financial Condition
  • 8-K: filed on 2023-03-29:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-30:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

  • 144: filed on 2023-05-31:
  • 144: filed on 2023-05-11:
  • 144: filed on 2023-05-11:
  • 144: filed on 2023-05-03:
  • 144: filed on 2023-04-24:
  • 144: filed on 2023-04-19:
  • 144: filed on 2023-05-25:
  • 144: filed on 2023-07-03:
  • 144: filed on 2023-08-04:

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    HEERY CHRISTOPHER CHIEF MEDICAL OFFICER

    • Officer
    		 7,795 2023-08-04 12

    LUBNER DAVID CHARLES

    • Director
    		 0 2023-06-14 1

    CARROLL JILL

    • Director
    		 0 2023-06-14 3

    BEHBAHANI ALI

    • Director
    		 0 2023-06-14 3

    WARE OLIVIA C

    • Director
    		 0 2023-06-14 1

    PATEL KAVITA

    • Director
    		 0 2023-06-14 1

    YOON DEREK

    • Director
    		 0 2023-06-14 1

    ELGHANDOUR RAMI SEE REMARKS

    • Officer
    • Director
    		 36,169 2023-05-31 3

    GILSON MICHELLE CHIEF FINANCIAL OFFICER

    • Officer
    		 9,485 2023-05-23 2

    SR ONE CAPITAL MANAGEMENT, LLC

    SR ONE CAPITAL FUND I AGGREGATOR LP

    SR ONE CAPITAL PARTNERS I, LP

    GEORGE SIMEON

    SR ONE CO-INVEST II, LLC

    SR ONE CO-INVEST II MANAGER, LLC

    • 10% Owner
    		 8,984,637 2023-05-11 1

    SANDELL SCOTT D

    • 10% Owner
    		 4,746,494 2022-12-23 2

    BASKETT FOREST

    • 10% Owner
    		 4,745,262 2022-12-20 1

    SONSINI PETER W.

    • 10% Owner
    		 4,746,083 2022-12-20 1

    FLORENCE ANTHONY A. JR.

    • 10% Owner
    		 4,745,441 2022-12-20 1

    NEW ENTERPRISE ASSOCIATES 15, L.P.

    • 10% Owner
    		 4,745,262 2022-12-20 1

    MAKHZOUMI MOHAMAD

    • 10% Owner
    		 4,745,545 2022-12-20 1

    NEA PARTNERS 15, L.P.

    NEA 15 GP, LLC

    • 10% Owner
    		 4,745,262 2022-12-20 1

    NEW ENTERPRISE ASSOCIATES 15, L.P.

    SANDELL SCOTT D

    SONSINI PETER W.

    NEA PARTNERS 15, L.P.

    NEA 15 GP, LLC

    MAKHZOUMI MOHAMAD

    FLORENCE ANTHONY A. JR.

    BASKETT FOREST

    • 10% Owner
    		 6,745,262 2022-06-21 2

    NOVO HOLDINGS A/S

    • 10% Owner
    		 4,016,878 2022-02-08 0

    WILLIAMS LEWIS T

    • Director
    		 2,095,114 2022-02-08 0

    THIBAULT LANCE E SEE REMARKS

    • Officer
    		 0 2022-02-03 0

    SR ONE CAPITAL MANAGEMENT, LLC

    SR ONE CAPITAL FUND I AGGREGATOR LP

    SR ONE CAPITAL PARTNERS I, LP

    SR ONE CO-INVEST II, LLC

    GEORGE SIMEON

    • 10% Owner
    		 0 2022-02-03 1

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ARCELLX INC ACLX 2023-12-05 17:15:04 UTC 4.7177 0.6023 450000
    ARCELLX INC ACLX 2023-12-05 16:45:04 UTC 4.7177 0.6023 450000
    ARCELLX INC ACLX 2023-12-05 16:15:04 UTC 4.7177 0.6023 450000
    ARCELLX INC ACLX 2023-12-05 15:45:04 UTC 4.6861 0.6339 450000
    ARCELLX INC ACLX 2023-12-05 15:15:05 UTC 4.6861 0.6339 450000
    ARCELLX INC ACLX 2023-12-05 14:45:03 UTC 4.6828 0.6372 450000
    ARCELLX INC ACLX 2023-12-05 14:15:04 UTC 4.6828 0.6372 450000
    ARCELLX INC ACLX 2023-12-05 13:45:04 UTC 4.6828 0.6372 450000
    ARCELLX INC ACLX 2023-12-05 13:15:04 UTC 4.6828 0.6372 450000
    ARCELLX INC ACLX 2023-12-05 12:45:05 UTC 4.6828 0.6372 450000
    ARCELLX INC ACLX 2023-12-04 22:15:04 UTC 4.6828 0.6372 400000
    ARCELLX INC ACLX 2023-12-04 21:45:03 UTC 4.6828 0.6372 400000
    ARCELLX INC ACLX 2023-12-04 21:15:03 UTC 4.6828 0.6372 400000
    ARCELLX INC ACLX 2023-12-04 20:45:04 UTC 4.6828 0.6372 400000
    ARCELLX INC ACLX 2023-12-04 20:15:05 UTC 4.6828 0.6372 400000
    ARCELLX INC ACLX 2023-12-04 19:45:03 UTC 4.6828 0.6372 400000
    ARCELLX INC ACLX 2023-12-04 19:15:04 UTC 4.6828 0.6372 400000
    ARCELLX INC ACLX 2023-12-04 18:45:04 UTC 4.6828 0.6372 400000
    ARCELLX INC ACLX 2023-12-04 18:15:05 UTC 4.6828 0.6372 400000
    ARCELLX INC ACLX 2023-12-04 17:45:03 UTC 4.6828 0.6372 400000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund ACLX -571.0 shares, $-19556.75 2023-07-31 N-PORT
    Meeder Funds- Spectrum Fund ACLX -2.0 shares, $-71.76 2023-09-30 N-PORT
    VANGUARD MONTGOMERY FUNDS- VANGUARD MARKET NEUTRAL FUND ACLX -43106.0 shares, $-1546643.28 2023-09-30 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments